Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 10/20 | 0.76 |
| ▸ | PGR | P06401 | 6/20 | 0.76 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.76 |
| ▸ | LMNA | P02545 | 3/20 | 0.76 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.76 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.76 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.76 |
| ▸ | IL5 | P05113 | 1/20 | 0.76 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.76 |
| ▸ | AR | P10275 | 1/20 | 0.76 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.76 |
| ▸ | MMP9 | P14780 | 1/20 | 0.76 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.76 |
| ▸ | THPO | P40225 | 1/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.76 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.76 |
| ▸ | BLM | P54132 | 1/20 | 0.76 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.76 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18051174 | 1.00 | NR3C1 (0.76) | NR3C1PGRHIF1ACYP3A4LMNA | |
| SCHEMBL19583457 | 1.00 | NR3C1 (0.76) | NR3C1PGRHIF1ACYP3A4LMNA | |
| SCHEMBL3305265 | 1.00 | NR3C1 (0.76) | NR3C1PGRHIF1ACYP3A4LMNA | |
| SCHEMBL13393103 | 0.96 | NR3C1 (0.70) | NR3C1PGRHIF1ACYP3A4LMNA | |
| SCHEMBL13393089 | 0.96 | NR3C1 (0.70) | NR3C1PGRHIF1ACYP3A4LMNA | |
| SCHEMBL13393086 | 0.96 | NR3C1 (0.70) | NR3C1PGRHIF1ACYP3A4LMNA | |
| SCHEMBL3300562 | 0.96 | NR3C1 (0.70) | NR3C1PGRHIF1ACYP3A4LMNA | |
| SCHEMBL13393081 | 0.96 | NR3C1 (0.70) | NR3C1PGRHIF1ACYP3A4LMNA | |
| SCHEMBL3305296 | 0.95 | NR3C1 (0.69) | NR3C1PGRHIF1ACYP3A4LMNA | |
| SCHEMBL21152598 | 0.93 | NR3C1 (0.77) | NR3C1PGRHIF1ACYP3A4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109152735-B | Lipid nanoparticles comprising lipophilic anti-inflammatory agents and methods of use thereof | 阿斯利康(瑞典)有限公司 | 2022-03-11 | — | — | CN | claimed |
| EP-3454835-B1 | LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF | ASTRAZENECA AB (SE) | 2021-03-31 | — | — | EP | claimed |
| EP-3454835-A1 | LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF | Astrazeneca AB (SE) | 2019-03-20 | — | — | EP | claimed |
| CN-109152735-A | Lipidic nanoparticles and its application method comprising lipophilicity anti-inflammatory agent | 阿斯利康(瑞典)有限公司 | 2019-01-04 | — | — | CN | claimed |
| US-20170367988-A1 | LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF | ASTRAZENECA AB (SE) | 2017-12-28 | — | — | US | claimed |
| WO-2017194454-A1 | LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF | ASTRAZENECA AB (SE) | 2017-11-16 | — | — | WO | claimed |
| CN-109152735-B | Lipid nanoparticles comprising lipophilic anti-inflammatory agents and methods of use thereof | 阿斯利康(瑞典)有限公司 | 2022-03-11 | — | — | CN | disclosed |
| EP-3454835-B1 | LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF | ASTRAZENECA AB (SE) | 2021-03-31 | — | — | EP | disclosed |
| EP-3454835-A1 | LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF | Astrazeneca AB (SE) | 2019-03-20 | — | — | EP | disclosed |
| CN-109152735-A | Lipidic nanoparticles and its application method comprising lipophilicity anti-inflammatory agent | 阿斯利康(瑞典)有限公司 | 2019-01-04 | — | — | CN | disclosed |
| US-20170367988-A1 | LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF | ASTRAZENECA AB (SE) | 2017-12-28 | — | — | US | disclosed |
| WO-2017194454-A1 | LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF | ASTRAZENECA AB (SE) | 2017-11-16 | — | — | WO | disclosed |